-
1
-
-
0001497768
-
Evolución del control de la hipertensión arterial en España. Resultados del estudio Controlpres 98
-
Coca A. Evolución del control de la hipertensión arterial en España. Resultados del estudio Controlpres 98. Hipertensión 1998; 15: 298-307.
-
(1998)
Hipertensión
, vol.15
, pp. 298-307
-
-
Coca, A.1
-
2
-
-
0344097511
-
Hypertension. Blood pressure in Spain: Distribution, awareness, control, and benefits of a reduction in average pressure
-
Banegas JR, Rodríguez-Artalejo F, de la Cruz F, Guallar-Castillón P, del Rey-Calero J. Hypertension. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension 1998; 32: 998-1002.
-
(1998)
Hypertension
, vol.32
, pp. 998-1002
-
-
Banegas, J.R.1
Rodríguez-Artalejo, F.2
De La Cruz, F.3
Guallar-Castillón, P.4
Del Rey-Calero, J.5
-
3
-
-
0025338681
-
Treating the individual hypertensive patient: Considerations on dose, sequential monotherapy and drug combinations
-
Brunner HR, Ménard J, Waeber B, et al. Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations. J Hypertens 1990; 8: 3-11.
-
(1990)
J Hypertens
, vol.8
, pp. 3-11
-
-
Brunner, H.R.1
Ménard, J.2
Waeber, B.3
-
4
-
-
0032513878
-
Effects of intensive lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial
-
for the HOT study group
-
Hansson L, Zanchetti A for the HOT study group. Effects of intensive lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755-62.
-
(1998)
Lancet
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
-
5
-
-
0030713021
-
The sixth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC VI)
-
Joint National Committee. The sixth report of The Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC VI). Arch Intern Med 1997; 157: 2413-45.
-
(1997)
Arch Intern Med
, vol.157
, pp. 2413-2445
-
-
-
6
-
-
0027326310
-
Treatment of mild hypertension study (TOMHS): Final results
-
Neaton JD, Grimm RH, Jr, Prineas RJ, et al. Treatment of mild hypertension study (TOMHS): final results. JAMA 1993; 270: 713-24.
-
(1993)
JAMA
, vol.270
, pp. 713-724
-
-
Neaton, J.D.1
Grimm Jr., R.H.2
Prineas, R.J.3
-
7
-
-
0027461577
-
Single-Drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo
-
Materson BJ, Reda DJ, Cushman WC, et al. Single-Drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Eng J Med 1993; 328: 914-21.
-
(1993)
N Eng J Med
, vol.328
, pp. 914-921
-
-
Materson, B.J.1
Reda, D.J.2
Cushman, W.C.3
-
8
-
-
0028834791
-
Results of combination anti-hypertensive therapy after failure of each of the components
-
Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents
-
Materson BJ, Reda DJ, Cushman WC, Henderson WG. Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents. J Hum Hypertens 1995; 9: 791-6.
-
(1995)
J Hum Hypertens
, vol.9
, pp. 791-796
-
-
Materson, B.J.1
Reda, D.J.2
Cushman, W.C.3
Henderson, W.G.4
-
9
-
-
0028869716
-
Doxazosin. An update of its clinical pharmacology and therapeutic Applications in hypertension and benign prostatic hyperplasia
-
Fulton B, Wagstaff AJ, Sorkin EM. Doxazosin. An update of its clinical pharmacology and therapeutic Applications in hypertension and benign prostatic hyperplasia. Drugs 1995; 49: 295-320.
-
(1995)
Drugs
, vol.49
, pp. 295-320
-
-
Fulton, B.1
Wagstaff, A.J.2
Sorkin, E.M.3
-
10
-
-
0025178604
-
Lowered levels of serum insulin, glucose and cholesterol in hypertensive patients during treatment with doxazosin
-
and the Finnish Multicenter Study Group
-
Lehtonen A and the Finnish Multicenter Study Group. Lowered levels of serum insulin, glucose and cholesterol in hypertensive patients during treatment with doxazosin. Curr Ther Res 1990; 47: 278-83.
-
(1990)
Curr Ther Res
, vol.47
, pp. 278-283
-
-
Lehtonen, A.1
-
11
-
-
0032749958
-
Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation
-
Chung M, Vashi V, Puente J, Sweeney M, Meredith P. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation. Br J Clin Pharmacol 1999; 48: 678-87.
-
(1999)
Br J Clin Pharmacol
, vol.48
, pp. 678-687
-
-
Chung, M.1
Vashi, V.2
Puente, J.3
Sweeney, M.4
Meredith, P.5
-
12
-
-
0032890927
-
Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension
-
for the doxazosin Investigators Study Group
-
Os I, Stokke HP for the doxazosin Investigators Study Group. Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension. J Cardiovasc Pharmacol 1999; 33: 791-7.
-
(1999)
J Cardiovasc Pharmacol
, vol.33
, pp. 791-797
-
-
Os, I.1
Stokke, H.P.2
-
14
-
-
0025234906
-
BP, stroke and coronary heart disease. Part 1. Prolonged difference in blood pressure prospective observational studies corrected for the regression dilution bias
-
MacMahon S, Peto R, Cutler J, et al. BP, stroke and coronary heart disease. Part 1. Prolonged difference in blood pressure prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74.
-
(1990)
Lancet
, vol.335
, pp. 765-774
-
-
MacMahon, S.1
Peto, R.2
Cutler, J.3
-
15
-
-
0035922695
-
Cardiovascular protection and blood pressure reduction: A meta-analysis
-
Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-15.
-
(2001)
Lancet
, vol.358
, pp. 1305-1315
-
-
Staessen, J.A.1
Wang, J.G.2
Thijs, L.3
-
16
-
-
0025886870
-
Metabolic consequences of treating hypertension
-
Pool PE, Seagren SC, Salel AF. Metabolic consequences of treating hypertension. Am J Hypertens 1991: 4 Suppl 7: 494-502S.
-
(1991)
Am J Hypertens
, vol.4
, Issue.SUPPL.
-
-
Pool, P.E.1
Seagren, S.C.2
Salel, A.F.3
-
17
-
-
1542748607
-
Doxazosin and lipid and lipoprotein metabolism
-
Betteridge DJ. Doxazosin and lipid and lipoprotein metabolism. Rev Contemp Pharmacother 1992; 3: 9-21.
-
(1992)
Rev Contemp Pharmacother
, vol.3
, pp. 9-21
-
-
Betteridge, D.J.1
-
18
-
-
9344253821
-
Long-term effects on plasma lipids of diet and drugs to treat hypertension
-
Grimm RH, Flack JM, Grandits G, et al. Long-term effects on plasma lipids of diet and drugs to treat hypertension. JAMA 1996; 275: 1549-56.
-
(1996)
JAMA
, vol.275
, pp. 1549-1556
-
-
Grimm, R.H.1
Flack, J.M.2
Grandits, G.3
-
19
-
-
0029991306
-
Principal results of the Hypertension and Lipid Trial (HALT): A multicenter study of doxazosin in patients with hypertension
-
Levy D, Walmsley P, Levenstein M. Principal results of the Hypertension and Lipid Trial (HALT): a multicenter study of doxazosin in patients with hypertension. Am Heart J 1996; 131: 966-73.
-
(1996)
Am Heart J
, vol.131
, pp. 966-973
-
-
Levy, D.1
Walmsley, P.2
Levenstein, M.3
-
20
-
-
0023197555
-
Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension
-
Trost BN, Weidmann P, Riesen W, Claessens J, Streulens Y, Nelemans F. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension. Am J Cardiol 1987; 59: 99-104G.
-
(1987)
Am J Cardiol
, vol.59
-
-
Trost, B.N.1
Weidmann, P.2
Riesen, W.3
Claessens, J.4
Streulens, Y.5
Nelemans, F.6
-
21
-
-
0029992345
-
Alfa-blockade and thiazide treatment of hypertension. A double-blind randomized trial comparing doxazosin and hydrochlorothiazide
-
Grimm RH, Flack JM, Schoenberger JA, Gonzalez NM, Liebson PR. Alfa-blockade and thiazide treatment of hypertension. A double-blind randomized trial comparing doxazosin and hydrochlorothiazide. Am J Hypertens 1996; 9: 445-54.
-
(1996)
Am J Hypertens
, vol.9
, pp. 445-454
-
-
Grimm, R.H.1
Flack, J.M.2
Schoenberger, J.A.3
Gonzalez, N.M.4
Liebson, P.R.5
-
22
-
-
0034126205
-
The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: A randomized, placebo-controlled study
-
Black HR, Sollins JS, Garofalo JL. The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: A randomized, placebo-controlled study. Am J Hypertens 2000; 13: 468-74.
-
(2000)
Am J Hypertens
, vol.13
, pp. 468-474
-
-
Black, H.R.1
Sollins, J.S.2
Garofalo, J.L.3
-
23
-
-
0034685403
-
Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlortalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
The ALLHAT Officers and coordinators for the ALLHAT Collaborative Research Group
-
The ALLHAT Officers and coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlortalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000; 283: 1967-75.
-
(2000)
JAMA
, vol.283
, pp. 1967-1975
-
-
|